Influence of microbial environment on autoimmunity

Nature Immunology

Volumn 11, Issue 1, 2010, Pages 28-35

  Chervonsky, Alexander V ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PATTERN RECOGNITION RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; COMMENSAL; GENETIC SUSCEPTIBILITY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MICROBIAL COMMUNITY; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; BACTERIAL INFECTION; BIOLOGICAL MODEL; IMMUNOLOGY; MICROBIOLOGY; MYCOSIS;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BACTERIAL INFECTIONS; HUMANS; IMMUNITY, INNATE; MODELS, BIOLOGICAL; MYCOSES; RECEPTORS, IMMUNOLOGIC;

EID: 74049161267     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1801     Document Type: Review

References (139)

1. Lo, S.S., Tun, R.Y., Hawa, M. & Leslie, R.D. Studies of diabetic twins. Diabetes Metab. Rev. 7, 223-238 (1991).
2. Block, S.R., winfield, J.B., Lockshin, M.D., D'Angelo, W.A. & Christian, C.L. Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am. J. Med. 59, 533-552 (1975).
3. Bach, J.F. The Effect of infections on susceptibILity to autoImmune and allergic diseases. N. Engl. J. Med. 347, 911-920 (2002).
4. Muntoni, S. New insights into the Epidemiology of type 1 diabetes in Mediterranean countries. Diabetes Metab. res. Rev. 15, 133-140 (1999).
5. Zipris, D. et al. TLR activation synergizes with KILham rat virus infection to induce diabetes in BBDR rats. J. Immunol. 174, 131-142 (2005).
6. Zipris, D. et al. TLR9-signaling pathways are involved in KILham rat virus-induced autoImmune diabetes in the biobreeding diabetes-resistant rat. J. Immunol. 178, 693-701 (2007).
7. Goverman, J. Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein. Immunol. Rev. 169, 147-159 (1999).
8. PozzILli, P., Signore, A., WILliams, A.J. & Beales, P.E. NOD mouse colonies around the world-recent facts and figures. Immunol. Today 14, 193-196 (1993).
9. Anderson, M.S. & Bluestone, J.A. The NOD mouse: a model of Immune dysregulation. Annu. Rev. Immunol. 23, 447-485 (2005).
10. Malkiel, S., Liao, L., Cunningham, M.W. & Diamond, B. T-cell-dependent antibody response to the dominant epitope of streptococcal polysaccharide, N-acetyl-glucosamine, is cross-reactive with cardiac myosin. Infect. Immun. 68, 5803-5808 (2000).
11. Oldstone, M.B. Molecular mimicry and Immune-mediated diseases. FaSeB J. 12, 1255-1265 (1998).
12. Benoist, C. & Mathis, D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2, 797-801 (2001).
13. Munz, C., Lunemann, J.D., Getts, M.T. & MILler, S.D. Antiviral Immune responses: triggers of or triggered by autoimmunity? Nat. Rev. Immunol. 9, 246-258 (2009).
14. MILler, S.D. et al. Persistent infection with TheILer's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3, 1133-1136 (1997).
15. Janeway, C.A. JR. Approaching the asymptote? evolution and revolution in immunology. cold Spring Harb. Symp. Quant. Biol. 54, 1-13 (1989).
16. Medzhitov, R. Approaching the asymptote: 20 years later. Immunity 30, 766-775 (2009)
17. Palm, N.W. & Medzhitov, R. Pattern Recognition receptors and control of adaptive immunity. Immunol. Rev. 227, 221-233 (2009).
18. Kawai, T. & Akira, S. The roles of TLRs, RLRs and NLRs in pathogen Recognition. Int. Immunol. 21, 317-337 (2009).
19. Davidson, A. & Diamond, B. AutoImmune diseases. N. Engl. J. Med. 345, 340-350 (2001).
20. McGonagle, D. & McDermott, M.F. A proposed classification of the immunological diseases. PloS Med. 3, e297 (2006).
21. Suzuki, T. et al. Diabetogenic Effects of lymphoctye transfusion on the NOD or NOD nude mouse. in Immune deficient animals in Biomedical research (eds. Rygaard, J., Graem, N. & Sprang-Thomsen, M.) 112-116 (Karger, Basel, Switzerland, 1987).
22. Wen, L. et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455, 1109-1113 (2008).
23. Rossini, A.A., WILliams, R.M., Mordes, J.P., Appel, M.C. & Like, A.A. Spontaneous diabetes in the gnotobiotic BB/w rat. Diabetes 28, 1031-1032 (1979).
24. Anderson, A.C. et al. High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J. Exp. Med. 191, 761-770 (2000).
25. Bjork, J., Kleinau, S., Midtvedt, T., Klareskog, L. & Smedegard, G. Role of the bowel flora for development of immunity to hsp 65 and arthritis in three experimental models. Scand. J. Immunol. 40, 648-652 (1994).
26. Rehakova, Z. et al. Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease. Hum. Immunol. 61, 555-558 (2000).
27. Sinkorova, Z., Capkova, J., Niederlova, J., Stepankova, R. & Sinkora, J. Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice. Hum. Immunol. 69, 845-850 (2008).
28. Maldonado, M.A. et al. The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J. Immunol. 162, 6322-6330 (1999).
29. Stranges, P.B. et al. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26, 629-641 (2007).
30. Gray, D.H., Gavanescu, I., Benoist, C. & Mathis, D. Danger-free autoImmune disease in Aire-deficient mice. Proc. Natl. Acad. Sci. USA 104, 18193-18198 (2007). The work revealed that APECED is independent of innate-adaptive connection, a prototypic Group II disease in our proposed classification.
31. Anderson, M.S. et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 298, 1395-1401 (2002).
32. Mathis, D. & Benoist, C. Aire. Annu. Rev. Immunol. 27, 287-312 (2009).
33. Hase, K. et al. Activation-induced cytidine deaminase deficiency causes organ-specific autoImmune disease. PloS one 3, e3033 (2008).
34. Kim, J.M., Rasmussen, J.P. & Rudensky, A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-197 (2007).
35. Abdollahi-Roodsaz, S. et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest. 118, 205-216 (2008).
36. Croker, B.A. et al. Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger. Proc. Natl. Acad. Sci. USA 105, 15028-15033 (2008).
37. Yu, C.C. et al. B and T cells are not required for the viable motheaten phenotype. J. Exp. Med. 183, 371-380 (1996).
38. Haas, T. et al. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. Immunity 28, 315-323 (2008).
39. Gewirtz, A.T., Navas, T.A., Lyons, S., Godowski, P.J. & Madara, J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proin-flammatory gene expression. J. Immunol. 167, 1882-1885 (2001).
40. Lee, J. et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 8, 1327-1336 (2006).
41. Napirei, M. et al. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25, 177-181 (2000).
42. Yasutomo, K. et al. Mutation of dnaSe1 in people with systemic lupus erythema-tosus. Nat. Genet. 28, 313-314 (2001).
43. Stetson, D.B., Ko, J.S., Heidmann, T. & Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587-598 (2008).
44. Yoshida, H., Okabe, Y., Kawane, K., Fukuyama, H. & Nagata, S. Lethal anemia caused by Interferon-β produced in mouse embryos carrying undigested DNA. Nat. Immunol. 6, 49-56 (2005).
45. Crow, Y.J. et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat. Genet. 38, 910-916 (2006).
46. Gaipl, U.S. et al. Clearance deficiency and systemic lupus erythematosus (SLe). J. autoimmun. 28, 114-121 (2007).
47. Pisitkun, P. et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312, 1669-1672 (2006).
48. Deane, J.A. et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27, 801-810 (2007).
49. Fairhurst, A.M. et al. Yaa autoImmune phenotypes are conferred by overexpression of TLR7. Eur. J. Immunol. 38, 1971-1978 (2008).
50. Sigurdsson, S. et al. Polymorphisms in the tyrosine kinase 2 and Interferon Regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 76, 528-537 (2005).
51. Miceli-Richard, C. et al. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum. 56, 3989-3994 (2007).
52. O'NeILl, L.A. & Bowie, A.G. The famILy of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7, 353-364 (2007).
53. Sigurdsson, S. et al. Comprehensive evaluation of the genetic variants of Interferon Regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum. Mol. Genet. 17, 872-881 (2008).
54. Richez, C. et al. TLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta priming. J. Immunol. 182, 820-828 (2009).
55. Lien, E. & Zipris, D. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Curr. Mol. Med. 9; 52-68 (2009).
56. Lang, K.S. et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoImmune disease. Nat. Med. 11, 138-145 (2005).
57. Garza, K.M. et al. enhanced T cell responses contribute to the genetic predisposition of CD8-mediated spontaneous autoimmunity. Eur. J. Immunol. 32, 885-894 (2002).
58. Horwitz, M.S. et al. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4, 781-785 (1998).
59. Ellerman, K.E. & Like, A.A. SusceptibILity to diabetes is widely distributed in normal class IIu haplotype rats. Diabetologia 43, 890-898 (2000).
60. LeibundGut-Landmann, S. et al. Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8, 630-638 (2007).
61. Acosta-Rodriguez, E.V. et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8; 639-646 (2007).
62. Manicassamy, S. et al. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T Regulatory responses and inhibits autoimmunity. Nat. Med. 15, 401-409 (2009).
63. Smyth, D.J. et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the Interferon-induced helicase (IFIH1) region. Nat. Genet. 38, 617-619 (2006).
64. Nejentsev, S., Walker, N., Riches, D., Egholm, M. & Todd, J.A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324, 387-389 (2009).
65. Maeda, S. et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307, 734-738 (2005).
66. Kobayashi, K.S. et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734 (2005)
67. Strober, W., Kitani, A., Fuss, I., Asano, N. & Watanabe, T. The molecular basis of NOD2 susceptibILity mutations in Crohn's disease. Mucosal Immunol. 1 (suppl. 1), S5-S9 (2008).
68. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232 (2006).
69. Gurcel, L., Abrami, L., Girardin, S., Tschopp, J. & van der Goot, F.G. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126, 1135-1145 (2006).
70. Masters, S.L., Simon, A., Aksentijevich, I. & Kastner, D.L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol. 27, 621-668 (2009).
71. Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
72. Ben-Sasson, S.Z. et al. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc. Natl. Acad. Sci. USA 106, 7119-7124 (2009).
73. Ichinohe, T., Lee, H.K., Ogura, Y., Flavell, R. & Iwasaki, A. Inflammasome Recognition of influenza virus is essential for adaptive Immune responses. J. Exp. Med. 206, 79-87 (2009).
74. H17-cell-mediated autoim-munity to environmental toxins. Nature 453, 106-109 (2008).
75. Stockinger, B., veldhoen, M. & Hirota, K. Modulation of Th17 development and function by activation of the aryl hydrocarbon receptor-the role of endogenous ligands. Eur. J. Immunol. 39, 652-654 (2009).
76. Matzinger, P. Tolerance, danger, and the extended famILy. Annu. Rev. Immunol. 12, 991-1045 (1994).
77. Matzinger, P. The danger model: a renewed sense of self. Science 296, 301-305 (2002).
78. Jin, M.S. et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130, 1071-1082 (2007).
79. Kim, H.M. et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran. Cell 130, 906-917 (2007).
80. Bianchi, M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. leukoc. Biol. 81, 1-5 (2007).
81. Kono, H. & Rock, K.L. How dying cells alert the Immune system to danger. Nat. Rev. Immunol. 8, 279-289 (2008).
82. Gao, B. & Tsan, M.F. Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages. J. Biol. chem. 278, 22523-22529 (2003).
83. Gao, B. & Tsan, M.F. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J. Biol. chem. 278, 174-179 (2003).
84. Kovalchin, J.T. et al. In vivo delivery of heat shock protein 70 accelerates wound healing by up-regulating macrophage-mediated phagocytosis. Wound Repair Regen. 14, 129-137 (2006).
85. Schauber, J. et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 117, 803-811 (2007).
86. GILliet, M. & Lande, R. Antimicrobial peptides and self-DNA in autoImmune skin inflammation. Curr. opin. Immunol. 20, 401-407 (2008).
87. Rakoff-Nahoum, S., Paglino, J., Eslami-varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
88. Medzhitov, R. Origin and physiological roles of inflammation. Nature 454, 428-435 (2008).
89. Green, D.R., Ferguson, T., Zitvogel, L. & Kroemer, G. Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 9, 353-363 (2009).
90. Bianchi, M.E. & Manfredi, A.A. High-mobILity group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 220, 35-46 (2007).
91. Grover, A. et al. Mycobacterial infection induces the secretion of high-mobILity group box 1 protein. Cell. Microbiol. 10, 1390-1404 (2008).
92. Degryse, B. et al. The high mobILity group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152, 1197-1206 (2001).
93. Straino, S. et al. High-mobILity group box 1 protein in human and murine skin: involvement in wound healing. J. Invest. dermatol. 128, 1545-1553 (2008)
94. Ranzato, E., Patrone, M., Pedrazzi, M. & Burlando, B. HMGb1 promotes scratch wound closure of HaCaT keratinocytes via eRK1/2 activation. Mol. Cell Biochem. published online, doi:10.1007/s11010-009-0192-4 (9 July 2009).
95. Chen, G.Y., Tang, J., Zheng, P. & Liu, Y. CD24 and Siglec-10 selectively repress tissue damage-induced Immune responses. Science 323, 1722-1725 (2009).
96. Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569 (2007).
97. Tian, J. et al. Toll-like receptor 9-dependent activation by DNA-containing Immune complexes is mediated by HMGB1 and RAGe. Nat. Immunol. 8, 487-496 (2007).
98. Leadbetter, E.A. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607 (2002).
99. Schaschl, H., Aitman, T.J. & Vyse, T.J. Copy number variation in the human genome and its implication in autoimmunity. Clin. exp. Immunol. 156, 12-16 (2009).
100. H17 cell differentiation. Nature 458, 78-82 (2009).
101. Kim, H.S. et al. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoImmune diabetes. Immunity 27, 321-333 (2007).
102. Kelly, D., Conway, S. & Aminov, R. Commensal gut bacteria: mechanisms of Immune modulation. Trends Immunol. 26, 326-333 (2005).
103. Macpherson, A.J. & Slack, E. The functional Interactions of commensal bacteria with intestinal secretory IgA. Curr. opin. Gastroenterol. 23, 673-678 (2007).
104. Hooper, L.V. Do symbiotic bacteria subvert host immunity? Nat. Rev. Microbiol. 7, 367-374 (2009).
105. Hooper, L.V. et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881-884 (2001).
106. Hooper, L.V. & Gordon, J.I. Commensal host-bacterial relationships in the gut. Science 292, 1115-1118 (2001).
107. Bauer, H., Horowitz, R.E., Levenson, S.M. & Popper, H. The response of the lymphatic tissue to the microbial flora. Studies on germfree mice. Am. J. Pathol. 42, 471-483 (1963).
108. Yamanaka, T. et al. Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J. Immunol. 170, 816-822 (2003).
109. Bouskra, D. et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507-510 (2008).
110. Stappenbeck, T.S., Hooper, L.V. & Gordon, J.I. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. USA 99, 15451-15455 (2002).
111. GILl, S.R. et al. Metagenomic analysis of the human distal gut microbiome. Science 312, 1355-1359 (2006).
112. Turnbaugh, P.J. et al. The human microbiome project. Nature 449, 804-810 (2007).
113. Huber, J.A. et al. Microbial population structures in the deep marine biosphere. Science 318, 97-100 (2007).
114. Ley, R.E., Turnbaugh, P.J., Klein, S. & Gordon, J.I. Microbial ecology: human gut microbes associated with obesity. Nature 444; 1022-1023 (2006).
115. Turnbaugh, P.J. et al. A core gut microbiome in obese and lean twins. Nature 457, 480-484 (2009).
116. + cells. Nat. Immunol. 10, 83-91 (2009).
117. Takatori, H. et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206, 35-41 (2009).
118. Ivanov, I.I. et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337-349 (2008).
119. Calcinaro, F. et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoImmune diabetes in the non-obese diabetic mouse. diabetologia 48, 1565-1575 (2005).
120. Slack, E. et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325; 617-620 (2009).
121. Wong, F.S. et al. The role of Toll-like receptors 3 and 9 in the development of autoImmune diabetes in NOD mice. Ann. NY Acad. Sci. 1150, 146-148 (2008).
122. Richer, M.J. & Horwitz, M.S. Viral infections in the pathogenesis of autoImmune diseases: focus on type 1 diabetes. Front. BioscI. 13, 4241-4257 (2008).
123. Zipris, D. Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanisms. Clin. Immunol. 131; 11-23 (2009).
124. Barton, E.S. et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326-329 (2007).
125. Hensley, S.E. et al. Murine norovirus infection has no significant Effect on adaptive immunity to vaccinia virus or influenza A virus. J. Virol. 83, 7357-7360 (2009).
126. Robertson, S.J. et al. Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus. J. Virol. 82, 408-418 (2008).
127. Manolio, T.A., Brooks, L.D. & Collins, F.S.A. HapMap harvest of insights into the genetics of common disease. J. Clin. Invest. 118, 1590-1605 (2008).
128. Ueda, H. et al. Association of the T-cell Regulatory gene CTLA4 with susceptibILity to autoImmune disease. Nature 423, 506-511 (2003).
129. Bottini, N. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36, 337-338 (2004).
130. Lowe, C.E. et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat. Genet. 39, 1074-1082 (2007).
131. Grant, S.F. et al. Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes 58, 290-295 (2009).
132. Loeser, S. & Penninger, J.M. Regulation of peripheral T cell tolerance by the e3 ubiquitin ligase Cbl-b. Semin. Immunol. 19, 206-214 (2007). (Pubitemid 46810290)
133. Gregersen, P.K. & Olsson, L.M. Recent advances in the genetics of autoImmune disease. Annu. Rev. Immunol. 27, 363-391 (2009).
134. Smyth, D.J. et al. PTPN22 Trp620 explains the association of chromosome 1p13 with type 1 diabetes and shows a statistical interaction with HLA class II genotypes. Diabetes 57, 1730-1737 (2008).
135. Ridgway, W.M. et al. Gene-gene Interactions in the NOD mouse model of type 1 diabetes. Adv. Immunol. 100; 151-175 (2008).
136. Duty, J.A. et al. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J. Exp. Med. 206, 139-151 (2009).
137. Blander, J.M. & Medzhitov, R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440, 808-812 (2006).
138. Blander, J.M. & Medzhitov, R. On regulation of phagosome maturation and antigen presentation. Nat. Immunol. 7, 1029-1035 (2006).
139. Chen, M. et al. Dendritic cell apoptosis in the maintenance of Immune tolerance. Science 311, 1160-1164 (2006).